about
Molecular pathology of prostate cancerA novel mutation in β integrin reveals an integrin-mediated interaction between the extracellular matrix and cki-1/p27KIP1The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cellsTrop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.Therapeutic value of quinazoline-based compounds in prostate cancer.Significance of talin in cancer progression and metastasis.Prostate cancer regulatory networksProstate cancer susceptibility variants confer increased risk of disease progression.Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses.Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationSuppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levelsTargeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumBoth Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancerAkt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation.Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.Targeting constitutively activated β1 integrins inhibits prostate cancer metastasisAnalysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Integrins in prostate cancer progressionMEK4 function, genistein treatment, and invasion of human prostate cancer cellsBeta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.Integrin signaling aberrations in prostate cancer.Targeting anoikis resistance in prostate cancer metastasis.Emerging biomarkers of prostate cancer (Review)Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.Insulin-like growth factor 1 stimulation of androgen receptor activity requires β(1A) integrins.Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression.Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.
P2860
Q24672410-BAA73E6C-CE54-4D65-B5E5-57FC727E2096Q27325410-2FAEFEBF-6C50-47DF-AFF2-CAC16DF64EAEQ28118861-BA64F73A-C403-44EC-BF77-3D6921FFF59CQ30539832-54E62B10-4FD6-4139-8551-69F65626E6AFQ33416683-8BAEB5FC-CC97-48B0-84A1-E9A8B8145057Q33490113-74FDB75E-AB3E-47E6-8F88-7B4FD2E1CBDDQ33718142-CEDEC3E8-AA86-458F-B13C-2BABCA82E3DFQ33746225-1867A4DB-0E96-431D-9B6E-9965B8E3A87EQ33763551-9D4F0265-6E38-4664-87EE-4F67FAF9F4E3Q33960568-F0294D23-2D57-4DE4-B90A-85F7E876E95EQ34175836-C7067F70-68A7-4C53-B411-CBB465BDAE0CQ34385738-55D90631-B184-4237-AA29-F3DC4F72EAC0Q34649015-35DC48C0-F232-4DBE-B1B7-4829B5FA02CDQ34756280-91966B69-DD60-4C64-9DE9-AD613C9C9CA0Q35018529-ABAD5C83-1618-4D0F-9D22-241BF9591E1AQ35042977-58DB033A-8CC6-48EA-A637-C122F45A950AQ35218871-F83ABC14-8539-4BAC-9831-0BC3C583A362Q35907618-354B75C1-DF3A-4792-98CF-42E6F3237F62Q36065429-E6BEF23E-D07F-4231-8D68-5688E73CDBF0Q36166788-D4BB630A-9033-4AEE-BFDC-3AFEFBA7B5AEQ36322254-7505F619-A7E2-4F9E-93C5-24C04F318FCCQ36343101-E6EF46EC-F58B-4D1C-8844-1ED6EB7B9960Q36508627-5A36C221-B084-4F76-9442-819FBDD720D5Q36780787-7BF4F9E6-91E5-4E7D-94D7-9671FFBA02C9Q36951900-D584570C-AD72-4775-805F-5AC1ACBBBAEAQ37018397-32C4CEE9-ED2D-4E03-A162-E58EF5FF72BDQ37182177-C7011992-D791-4A99-9E1C-9A67DD72271DQ37309967-EAF0736F-5EF6-41B0-84F7-B52E29F1A2CFQ37426688-C8E58124-0D19-4667-B6EB-415C98D0564AQ37643449-85F61637-5998-4C25-8A0F-DE04C4323DBAQ37691830-B70E542D-19EC-44E2-9CAA-5F7FBC25F7AEQ38013967-FBC48082-D8C6-434E-9B8E-CD706ACF27A6Q38353546-00AE9EBC-765E-402E-B64D-5BF0B31374EEQ38739702-93E9B191-BC1F-48F3-AF24-B3FCF93328B8Q38756785-E9402D52-0996-4BC3-B62A-F8B01A94707EQ38822335-2A840609-385E-48DB-A3F7-7E9F6C5A665FQ38824206-B7FCE3DA-2AEA-42D2-85A9-1B21793EC1A0Q38923285-A599F6FA-705D-4EA6-9553-0D33E24BB5D8Q39027079-65813B05-01A2-416A-82A5-B60E0C6BDCA0Q39028687-28481C3C-5200-4A32-8073-2DDB475F96EE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Integrins and prostate cancer metastases.
@ast
Integrins and prostate cancer metastases.
@en
Integrins and prostate cancer metastases.
@nl
type
label
Integrins and prostate cancer metastases.
@ast
Integrins and prostate cancer metastases.
@en
Integrins and prostate cancer metastases.
@nl
prefLabel
Integrins and prostate cancer metastases.
@ast
Integrins and prostate cancer metastases.
@en
Integrins and prostate cancer metastases.
@nl
P356
P1476
Integrins and prostate cancer metastases
@en
P2093
P2888
P304
P356
10.1023/A:1015547830323
P577
2001-01-01T00:00:00Z
P6179
1000795329